goralatide has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bordessoule, D; Cransac, M; Frindel, E; Liozon, E; Pradelles, P; Rigaud, M; Venot, J | 1 |
| Chermann, JC; Coutton, C | 1 |
2 other study(ies) available for goralatide and HIV Coinfection
| Article | Year |
|---|---|
Serum levels of a negative regulator of cell proliferation (AcSDKP) are increased in certain human haemopathies.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Female; Hematopoiesis; Hematopoietic Stem Cells; HIV Infections; Humans; Immunoenzyme Techniques; Leukemia; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Molecular Sequence Data; Myeloproliferative Disorders; Oligopeptides | 1993 |
In vitro study of Seraspenide on HIV-induced inhibition of granulopoiesis.
Topics: Antigens, CD34; Cell Differentiation; Cells, Cultured; Culture Media, Conditioned; Granulocytes; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; HIV Infections; Humans; Leukocytes, Mononuclear; Oligopeptides; T-Lymphocyte Subsets | 1997 |